Following weeks of negotiations and four rejected bids, British neurology and orphan drug giant Shire has...
Up To Date
Latest News
Vas Narasimhan, the newly appointed CEO of Swiss pharma giant Novartis, introduced himself to the Swiss...
Swiss injection pen developer Haselmeier and Boston-based Common Sensing have partnered to develop smart...
The UK-based pioneer in marine biotechnologies Jellagen has closed a £3.8m funding round to boost sales of its...
Iterum Therapeutics plans to raise up to US$92m in an initial public offering on US technology stock market...
US biotech company Biogen has exercised the option of a one-off payment to Swiss developer Neurimmune. If...
Share
